Skip to content

Source filing unavailable

Q4 2010 · —
Revenue$83.54Mno prior Q4 2009 on file+14.0% vs Q3 2010
Net Income$37.47Mno prior Q4 2009 on file+15.4% vs Q3 2010
EPS Diluted$0.79no prior Q4 2009 on file+14.5% vs Q3 2010
Gross Profit$77,073,000—
Operating Cash Flowderived$22,791,000—
Free Cash Flowderived$22,678,000—
Margins · derived
Gross margin92.3%
Net margin44.9%

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

no prior Q4 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Jazz Pharmaceuticals plc · CIK 1232524 · Engraved from SEC EDGAR